Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23687 | 0.93 | — | — | |
| Water SCHEMBL5889074 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL30925320 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL8764642 | 0.89 | MEN1 (0.44) | MEN1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL78515 | 0.89 | — | — | |
| Hydroxyamine SCHEMBL7977355 | 0.89 | — | — | |
| Fluoride SCHEMBL11309264 | 0.89 | — | — | |
| Deanol SCHEMBL27486030 | 0.89 | MEN1 (0.50) | MEN1LMNAKMT2AGRM4 | |
| Deanol SCHEMBL609 | 0.89 | — | — | |
| Deanol SCHEMBL929892 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140245541-A1 | NOVEL OXIDATION DYE PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2014-09-04 | — | — | US | disclosed |
| US-8821592-B1 | Oxidation dye precursors | HENKEL AG & CO. KGAA (DE) | 2014-09-02 | — | — | US | disclosed |
| EP-2210914-A1 | FLAME RETARDANT COMPOSITION HAVING IMPROVED PROCESSABILITY, FLAME-RETARDANT SYNTHETIC RESIN COMPOSITION, AND MOLDED ARTICLE OF THE FLAME-RETARDANT SYNTHETIC RESIN COMPOSITION | Adeka Corporation (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-4126617-A | PROPHYLAXIS | THE UPJOHN COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-3959289-A | PROPHYLACTICS IN ALLERGIES | THE UPJOHN COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140245541-A1 | NOVEL OXIDATION DYE PRECURSORS | KRT18, SQOR, NDUFA5 | MEN1 4338/4885LMNA 826/4885KMT2A 2058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.